Fragata Isabel, Canto-Moreira Nuno, Canhão Patrícia
Neuroradiology Department, Hospital São José, Centro Hospitalar Lisboa Central, NOVA Medical School, Lisbon, Portugal.
Department of Neuroradiology, Department of Pediatric Radiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
Neuroradiology. 2018 Jun;60(6):609-616. doi: 10.1007/s00234-018-1997-1. Epub 2018 Mar 9.
Perimesencephalic hemorrhage (PMH) is a benign subtype of nonaneurysmal subarachnoid hemorrhage (SAH). We aimed to investigate if cerebral perfusion in PMH is less affected than in aneurysmal SAH (aSAH).
From a prospective cohort of 80 patients with spontaneous SAH, we included PMH patients (n = 15) and selected aSAH patients (n = 39) with similar clinical grade at admission (World Federation of Neurosurgeons Scale-WFNS I/II). Computed tomography (CT) perfusion was performed at < 72 h and/or at 8-10 days. Cerebral perfusion parameter values were compared between groups with nonparametric tests. Subgroup analyses compared PMH and aSAH patients stratified according to aneurysmal location (anterior or posterior circulation) and blood burden (Fisher grade).
At < 72 h, no significant differences in perfusion parameters were found between PMH and aSAH patients. At 8-10 days, PMH patients had lower MTT than aSAH patients, and a trend for higher CBF. PMH patients had higher CBF and CBV at < 72 h when compared to posterior circulation aSAH patients. When compared to aSAH patients with similar blood burden, PMH patients had higher CBF and lower MTT at < 72 h, and lower MTT at 8-10 days.
PMH patients had better cerebral perfusion compared to patients with aSAH, particularly during the vasospasm time window. After stratifying for the amount of blood, PMH patients also had better cerebral perfusion in the first 72 h after SAH. These results are in line with the better clinical presentation and prognosis of PMH, and possibly with a different etiology.
脑周出血(PMH)是非动脉瘤性蛛网膜下腔出血(SAH)的一种良性亚型。我们旨在研究PMH患者的脑灌注是否比动脉瘤性SAH(aSAH)患者受影响更小。
在一个由80例自发性SAH患者组成的前瞻性队列中,我们纳入了PMH患者(n = 15),并选取了入院时临床分级相似(世界神经外科医师联合会分级-WFNS I/II)的aSAH患者(n = 39)。在<72小时和/或8 - 10天时进行计算机断层扫描(CT)灌注检查。采用非参数检验比较两组的脑灌注参数值。亚组分析比较了根据动脉瘤位置(前循环或后循环)和血液负荷(Fisher分级)分层的PMH和aSAH患者。
在<72小时时,PMH和aSAH患者的灌注参数无显著差异。在8 - 10天时,PMH患者的平均通过时间(MTT)低于aSAH患者,且脑血流量(CBF)有升高趋势。与后循环aSAH患者相比,PMH患者在<72小时时CBF和脑血容量(CBV)更高。与血液负荷相似的aSAH患者相比,PMH患者在<72小时时CBF更高、MTT更低,在8 - 10天时MTT更低。
与aSAH患者相比,PMH患者的脑灌注更好,尤其是在血管痉挛时间窗内。在对出血量进行分层后,PMH患者在SAH后的前72小时脑灌注也更好。这些结果与PMH更好的临床表现和预后一致,可能与不同的病因有关。